Envista Holdings Corporation (NYSE:NVST) Receives Consensus Rating of “Hold” from Analysts

Envista Holdings Corporation (NYSE:NVST) has been assigned a consensus rating of “Hold” from the fifteen research firms that are currently covering the company, Marketbeat reports. Nine analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 12-month price objective among analysts that have covered the stock in the last year is $28.6667.

A number of equities analysts recently weighed in on the stock. Weiss Ratings lowered shares of Envista from a “hold (c)” rating to a “hold (c-)” rating in a research note on Monday, May 11th. JPMorgan Chase & Co. upped their target price on shares of Envista from $26.00 to $29.00 and gave the stock a “neutral” rating in a research note on Thursday, May 7th. Wall Street Zen lowered shares of Envista from a “strong-buy” rating to a “buy” rating in a research note on Saturday, May 9th. Evercore restated an “outperform” rating and set a $33.00 price objective on shares of Envista in a research note on Thursday, May 7th. Finally, Morgan Stanley increased their price objective on shares of Envista from $19.00 to $21.00 and gave the stock an “equal weight” rating in a research note on Friday, April 24th.

Hedge Funds Weigh In On Envista

A number of large investors have recently modified their holdings of the business. Parallel Advisors LLC boosted its stake in shares of Envista by 13.1% during the 4th quarter. Parallel Advisors LLC now owns 3,175 shares of the company’s stock worth $69,000 after buying an additional 367 shares during the last quarter. Bank of Montreal Can boosted its stake in shares of Envista by 1.4% during the 4th quarter. Bank of Montreal Can now owns 26,178 shares of the company’s stock worth $568,000 after buying an additional 372 shares during the last quarter. Sepio Capital LP boosted its stake in shares of Envista by 1.2% during the 4th quarter. Sepio Capital LP now owns 31,632 shares of the company’s stock worth $687,000 after buying an additional 374 shares during the last quarter. Deutsche Bank AG boosted its stake in shares of Envista by 2.9% during the 4th quarter. Deutsche Bank AG now owns 17,412 shares of the company’s stock worth $378,000 after buying an additional 484 shares during the last quarter. Finally, State of Michigan Retirement System boosted its stake in shares of Envista by 1.5% during the 1st quarter. State of Michigan Retirement System now owns 39,463 shares of the company’s stock worth $1,001,000 after buying an additional 600 shares during the last quarter.

Envista Price Performance

Shares of NYSE NVST opened at $24.54 on Monday. The firm has a market cap of $3.99 billion, a PE ratio of 59.86, a PEG ratio of 1.39 and a beta of 0.88. The company has a current ratio of 2.44, a quick ratio of 2.06 and a debt-to-equity ratio of 0.47. Envista has a 1-year low of $18.25 and a 1-year high of $30.42. The company has a fifty day moving average price of $25.02 and a 200 day moving average price of $24.74.

Envista (NYSE:NVST) last announced its earnings results on Wednesday, May 6th. The company reported $0.36 earnings per share for the quarter, topping analysts’ consensus estimates of $0.31 by $0.05. The firm had revenue of $705.50 million during the quarter, compared to analyst estimates of $680.04 million. Envista had a net margin of 2.41% and a return on equity of 7.11%. The company’s revenue for the quarter was up 14.4% compared to the same quarter last year. During the same period in the prior year, the business earned $0.24 EPS. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. Research analysts predict that Envista will post 1.42 earnings per share for the current fiscal year.

Envista Company Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.